| pH-sensitive nanodrug carriers for codelivery of ERK inhibitor and gemcitabine enhance the inhibition of tumor growth in pancreatic cancer P Ray, D Dutta, I Haque, G Nair, J Mohammed, M Parmer, N Kale, M Orr, ... Molecular Pharmaceutics 18 (1), 87-100, 2020 | 51 | 2020 |
| Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer P Ray, G Nair, A Ghosh, S Banerjee, MY Golovko, SK Banerjee, ... Journal of cell communication and signaling 13, 407-420, 2019 | 33 | 2019 |
| Cellulose nanofibers as Scaffold-forming materials for thin film drug delivery systems MRH Khan, RS Hazra, G Nair, J Mohammad, L Jiang, K Reindl, ... International Journal of Pharmaceutics 627, 122189, 2022 | 15 | 2022 |
| Polymeric composite matrix with high biobased content as pharmaceutically relevant molecular encapsulation and release platform RS Hazra, D Dutta, B Mamnoon, G Nair, A Knight, S Mallik, S Ganai, ... ACS Applied Materials & Interfaces 13 (34), 40229-40248, 2021 | 15 | 2021 |
| Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanoparticle Form in Pancreatic Cancer Models GG Nair, ED Linster, P Ray, MA Quadir, KM Reindl International Journal of Molecular and Cellular Medicine 13 (3), 220, 2024 | | 2024 |
| Abstract B069: Inhibiting pancreatic cancer growth by dual targeting of ERK and PI3K signaling GG Nair, K Reindl, M Quadir Cancer Research 82 (22_Supplement), B069-B069, 2022 | | 2022 |
| Inhibiting pancreatic cancer growth by dual targeting of ERK and PI3K signaling. GG Nair, K Reindl, M Quadir CANCER RESEARCH 82 (22), 104-104, 2022 | | 2022 |
